홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

1-Hydroxybenzotriazole → Oritavancin

HRID 1397132
노트
인쇄 미리보기

반응식

HRID 1397132 반응식
[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@@H:9]2[C:113]3[CH:114]=[CH:115][C:110](=[C:111]([Cl:116])[CH:112]=3)[O:109][C:37]3=[C:38]([O:73][C@@H:74]4[O:79][C@H:78]([CH2:80][OH:81])[C@@H:77]([OH:82])[C@H:76]([OH:83])[C@H:75]4[O:84][C@@H:85]4[O:90][C@@H:89]([CH3:91])[C@H:88]([OH:92])[C@:87]([NH:94][CH2:95][C:96]5[CH:101]=[CH:100][C:99]([C:102]6[CH:107]=[CH:106][C:105]([Cl:108])=[CH:104][CH:103]=6)=[CH:98][CH:97]=5)([CH3:93])[CH2:86]4)[C:39]4[O:41][C:42]5[CH:47]=[CH:46][C:45]([C@@H:48]([OH:71])[C@@H:49]([NH:61][C:62]([C@H:64]([NH:69][CH3:70])[CH2:65][CH:66]([CH3:68])[CH3:67])=[O:63])[C:50]([NH:52][C@@H:53]([CH2:57][C:58]([NH2:60])=[O:59])[C:54]([NH:56][C@H:34]([C:35]([CH:40]=4)=[CH:36]3)[C:32](=[O:33])[NH:31][C@H:27]3[C:28]([NH:30][C@@H:10]2[C:11]([NH:13][C@H:14]([C:120]([OH:122])=[O:121])[C:15]2[C:20]([C:21]4[CH:26]=[C:25]3[CH:24]=[CH:23][C:22]=4[OH:117])=[C:19]([OH:118])[CH:18]=[C:17]([OH:119])[CH:16]=2)=[O:12])=[O:29])=[O:55])=[O:51])=[CH:44][C:43]=5[Cl:72])[CH2:5][C@@:4]([NH2:124])([CH3:123])[C@H:3]1[OH:125].OP(O)(O)=O.OP(O)(O)=O.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.CN(C)CCN(C)C(=O)CO>CS(C)=O.CN(C=O)C.C(OCC)C>[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@H:9]2[C@@H:10]3[NH:30][C:28](=[O:29])[C@@H:27]([C:25]4[CH:24]=[CH:23][C:22]([OH:117])=[C:21]([C:20]5[C:19]([OH:118])=[CH:18][C:17]([OH:119])=[CH:16][C:15]=5[C@@H:14]([C:120]([OH:122])=[O:121])[NH:13][C:11]3=[O:12])[CH:26]=4)[NH:31][C:32](=[O:33])[C@H:34]3[C:35]4=[CH:40][C:39]([O:41][C:42]5[CH:47]=[CH:46][C:45]([C@@H:48]([OH:71])[C@@H:49]([NH:61][C:62]([C@H:64]([NH:69][CH3:70])[CH2:65][CH:66]([CH3:67])[CH3:68])=[O:63])[C:50]([NH:52][C@@H:53]([CH2:57][C:58]([NH2:60])=[O:59])[C:54]([NH:56]3)=[O:55])=[O:51])=[CH:44][C:43]=5[Cl:72])=[C:38]([O:73][C@@H:74]3[O:79][C@H:78]([CH2:80][OH:81])[C@@H:77]([OH:82])[C@H:76]([OH:83])[C@H:75]3[O:84][C@@H:85]3[O:90][C@@H:89]([CH3:91])[C@H:88]([OH:92])[C@:87]([NH:94][CH2:95][C:96]5[CH:97]=[CH:98][C:99]([C:102]6[CH:103]=[CH:104][C:105]([Cl:108])=[CH:106][CH:107]=6)=[CH:100][CH:101]=5)([CH3:93])[CH2:86]3)[C:37](=[CH:36]4)[O:109][C:110]3=[C:111]([Cl:116])[CH:112]=[C:113]2[CH:114]=[CH:115]3)[CH2:5][C@@:4]([NH2:124])([CH3:123])[C@H:3]1[OH:125]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 5

HCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 53297457Oritavancin DiphosphateHCID 54488530N-(2-(Dimethylamino)ethyl)-2-Hydroxy-N-methylacetamide

생성물 1

HCID 16136912Oritavancin

시약·촉매·용매 3

HCID 679Dimethyl Sulfoxide용매HCID 3283Diethyl Ether용매HCID 6228Dimethylformamide용매2회

실험 절차

Oritavancin diphosphate 5 (630.7 mg, 0.3171 mmol), HBTU (601.1 mg, 1.585 mmol) and HOBt (173.4 mg, 1.283 mmol) was dissolved in the mixture of DMSO (4 mL) and DMF (8 mL) and 0.4 mL (2.296 mmol) of DIPEA was added. After stirring at room temperature for 30 min, the solution of 102 in 1 mL DMF was added plus 1 mL rinse. A yellow clear solution was obtained. After 2 days, 250 mL of diethyl ether was added to the reaction while stirring. After stand for a few min, the clear solution was decanted. The process was repeated with another 150 mL of diethyl ether. The residual mixture was dried in vacuo. The product was purified on repetitive C18 flash columns on a Biotage automatic chromatography system with gradient elution of H3PO4 (30 mM)-triethylamine (20 mM) buffer (aq, pH3)/methanol and then C18 column on Biotage system with gradient elution of 0.1% formic acid buffer (aq, pH2)/methanol. The purified product is a white solid as penta-formate salt (43.2 mg, 6%): ESI-MS calculated for C93H111Cl3N12O27: calculated 484.8 (M/4+H), 646.1 (M/3+H), 967.6 (M/2+H). found: 484.6, 646.0, 967.6.

후처리

  1. additionwas added
  2. washrinse
  3. customA yellow clear solution was obtained
  4. waitAfter 2 days
  5. stirringwhile stirring
  6. customAfter stand for a few min, the clear solution was decanted
  7. customThe residual mixture was dried in vacuo
  8. customThe product was purified on repetitive C18 flash columns on a Biotage automatic chromatography system with gradient elution of H3PO4 (30 mM)-triethylamine (20 mM) buffer (aq, pH3)/methanol
  9. washC18 column on Biotage system with gradient elution of 0.1% formic acid buffer (aq, pH2)/methanol

출처 및 근거

ORD 기록
ord-c6f2724223b84a21bfe9883bcfe2c70a
출처 데이터셋
uspto-grants-2014_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08901072B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트